Literature DB >> 18549405

Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses.

Akiko Miyagi Maeshima1, Mutsuko Omatsu, Junko Nomoto, Dai Maruyama, Sung-Won Kim, Takashi Watanabe, Yukio Kobayashi, Kensei Tobinai, Yoshihiro Matsuno.   

Abstract

Follicular lymphoma (FL) is one of the most common subtypes of non-Hodgkin lymphoma and frequently transforms to diffuse large B-cell lymphoma (DLBCL). To clarify some aspects of the natural history of FL, we retrospectively examined 43 consecutive patients who had DLBCL with pre- or coexisting FL grade 1 or 2. The patients comprised 22 men and 21 women with a median age of 53 years. Most of the patients (34/43) showed advanced-stage (III or IV) disease initially. We examined both FL and DLBCL components morphologically, immunohistochemically, and by interface fluorescence in situ hybridization (FISH: IGH/BCL2 fusion, BCL6 translocation) analysis. Most of the DLBCLs were classified as the centroblastic subtype, with two exceptions of the anaplastic subtype. Immunohistochemical analysis of both the FL and DLBCL components revealed the following respective positivity rates: CD20 100%/100%, CD10 86%/66%, Bcl-2 96%/91%, Bcl-6 84%/88%, MUM1 16%/34%, CD30 0%/20%, CD138 0%/0%, and CD5 0%/3%. Loss of CD10 (6/36, 17%) and gain of MUM1 (7/28, 25%) and CD30 (5/21, 24%) through transformation were not infrequent. High positivity rates for Bcl-2 and Bcl-6 were maintained throughout transformation. Among the DLBCLs, 84% were classified as the germinal center B-cell phenotype (GCB) and 16% as non-GCB in accordance with the criteria of Hans et al. IGH/BCL2 fusion was detected by FISH in 89% of FLs and 82% of DLBCLs. BCL6 translocation was detected in 1/6 (17%) DLBCLs without IGH/BCL2 fusion. Thus, although the morphological features and FISH results for DLBCL were consistent with transformed FL, the immunophenotype showed wide heterogeneity.

Entities:  

Mesh:

Year:  2008        PMID: 18549405     DOI: 10.1111/j.1349-7006.2008.00873.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

Review 1.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

2.  Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients.

Authors:  Akiko Miyagi Maeshima; Hirokazu Taniguchi; Yuta Ito; Shunsuke Hatta; Tomotaka Suzuki; Sayako Yuda; Shinichi Makita; Suguru Fukuhara; Wataru Munakata; Tatsuya Suzuki; Dai Maruyama; Koji Izutsu
Journal:  Int J Hematol       Date:  2019-06-11       Impact factor: 2.490

3.  Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.

Authors:  Toshiki Yamada; Takeshi Hara; Naoe Goto; Hitoshi Iwata; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2019-03-11       Impact factor: 2.490

4.  Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.

Authors:  Dai Maruyama; Takashi Watanabe; Akiko Miyagi Maeshima; Junko Nomoto; Hirokazu Taniguchi; Teruhisa Azuma; Masakazu Mori; Wataru Munakata; Sung-Won Kim; Yukio Kobayashi; Yoshihiro Matsuno; Kensei Tobinai
Journal:  Int J Hematol       Date:  2010-12-01       Impact factor: 2.490

5.  BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.

Authors:  Cristina Correia; Paula A Schneider; Haiming Dai; Ahmet Dogan; Matthew J Maurer; Amy K Church; Anne J Novak; Andrew L Feldman; Xiaosheng Wu; Husheng Ding; X Wei Meng; James R Cerhan; Susan L Slager; William R Macon; Thomas M Habermann; Judith E Karp; Steven D Gore; Neil E Kay; Diane F Jelinek; Thomas E Witzig; Grzegorz S Nowakowski; Scott H Kaufmann
Journal:  Blood       Date:  2014-12-01       Impact factor: 22.113

6.  Follicular lymphoma transforming into anaplastic diffuse large B-cell lymphoma of oral cavity: A case report with review of literature.

Authors:  Megha Mittal; Abhiney Puri; Rajat Nangia; Alisha Sachdeva
Journal:  J Oral Maxillofac Pathol       Date:  2015 Sep-Dec

7.  Gastric follicular lymphoma: A report of 3 cases and a review of the literature.

Authors:  Hee Young Na; Young A Kim; Cheol Lee; Ji-Young Choe; Seon Ah Shin; Jung-Weon Shim; Soo Kee Min; Hyun-Jung Kim; Jae Ho Han; Ji Eun Kim
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.